CoChat

The Cellular Senescence Stress Response in Post-Mitotic Brain Cells: Cell Survival at the Expense of Tissue Degeneration

Open access
Sah, Eric, Krishnamurthy, Sudarshan, Ahmidouch, Mohamed Y., Gillispie, Gregory J., Milligan, Carol, Orr, Miranda E. · 2021 · Life
Cited by 55

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Abstract

In 1960, Rita Levi-Montalcini and Barbara Booker made an observation that transformed neuroscience: as neurons mature, they become apoptosis resistant. The following year Leonard Hayflick and Paul Moorhead described a stable replicative arrest of cells in vitro, termed “senescence”. For nearly 60 years, the cell biology fields of neuroscience and senescence ran in parallel, each separately defining phenotypes and uncovering molecular mediators to explain the 1960s observations of their founding mothers and fathers, respectively. During this time neuroscientists have consistently observed the remarkable ability of neurons to survive. Despite residing in environments of chronic inflammation and degeneration, as occurs in numerous neurodegenerative diseases, often times the neurons with highest levels of pathology resist death. Similarly, cellular senescence (hereon referred to simply as “senescence”) now is recognized as a complex stress response that culminates with a change in cell fate. Instead of reacting to cellular/DNA damage by proliferation or apoptosis, senescent cells survive in a stable cell cycle arrest. Senescent cells simultaneously contribute to chronic tissue degeneration by secreting deleterious molecules that negatively impact surrounding cells. These fields have finally collided. Neuroscientists have begun applying concepts of senescence to the brain, including post-mitotic cells. This initially presented conceptual challenges to senescence cell biologists. Nonetheless, efforts to understand senescence in the context of brain aging and neurodegenerative disease and injury emerged and are advancing the field. The present review uses pre-defined criteria to evaluate evidence for post-mitotic brain cell senescence. A closer interaction between neuro and senescent cell biologists has potential to advance both disciplines and explain fundamental questions that have plagued their fields for decades.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/life11030229

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 72 references

Research works printed but not linked: 115

  1. Booker, 1960, Destruction of the Sympathetic Ganglia in Mammals by an Antiserum to a Nerve-Growth Protein, Proc. Natl. Acad. Sci. USA, 46, 384, 10.1073/pnas.46.3.384 · DOI · Paper page
  2. Oppenheim, R., and Milligan, C. (2017). Programmed Cell Death. Neuroscience and Biobehavioral Psychology, Elsevier. · DOI
  3. Fricker, 2018, Neuronal Cell Death, Physiol. Rev., 98, 813, 10.1152/physrev.00011.2017 · DOI · Paper page
  4. Greene, 2007, Cell cycle molecules define a pathway required for neuron death in development and disease, Biochim. Biophys. Acta, 1772, 392, 10.1016/j.bbadis.2006.12.003 · DOI
  5. Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
  6. Hayflick, 1965, The Limited in Vitro Lifetime of Human Diploid Cell Strains, Exp. Cell Res., 37, 614, 10.1016/0014-4827(65)90211-9 · DOI · Paper page
  7. Nehme, 2018, Hallmarks of Cellular Senescence, Trends Cell Biol., 28, 436, 10.1016/j.tcb.2018.02.001 · DOI · Paper page
  8. Dodig, 2019, Hallmarks of senescence and aging, Biochem. Med., 29, 030501, 10.11613/BM.2019.030501 · DOI · Paper page
  9. Gillispie, G.J., Sah, E., Krishnamurthy, S., Ahmidouch, M.Y., Zhang, B., and Orr, M.E. (2021). Evidence of the Cellular Senescence Stress Response in Mitotically Active Brain Cells-Implications for Cancer and Neurodegeneration. Life, 11. · DOI
  10. Fontana, 2020, Pathological Aspects of Neuronal Hyperploidization in Alzheimer’s Disease Evidenced by Computer Simulation, Front. Genet., 11, 287, 10.3389/fgene.2020.00287 · DOI
  11. Ain, 2018, Cell cycle-dependent and -independent telomere shortening accompanies murine brain aging, Aging, 10, 3397, 10.18632/aging.101655 · DOI · Paper page
  12. Gilson, 2020, Long-lived post-mitotic cell aging: Is a telomere clock at play?, Mech. Ageing Dev., 189, 111256, 10.1016/j.mad.2020.111256 · DOI
  13. Mosch, 2007, Aneuploidy and DNA replication in the normal human brain and Alzheimer’s disease, J. Neurosci., 27, 6859, 10.1523/JNEUROSCI.0379-07.2007 · DOI · Paper page
  14. Fischer, 2012, Changes in neuronal DNA content variation in the human brain during aging, Aging Cell, 11, 628, 10.1111/j.1474-9726.2012.00826.x · DOI · Paper page
  15. Varvel, 2008, Abeta oligomers induce neuronal cell cycle events in Alzheimer’s disease, J. Neurosci., 28, 10786, 10.1523/JNEUROSCI.2441-08.2008 · DOI · Paper page
  16. Modi, 2016, Regulation of Neuronal Cell Cycle and Apoptosis by MicroRNA 34a, Mol. Cell. Biol., 36, 84, 10.1128/MCB.00589-15 · DOI · Paper page
  17. Chauhan, 2020, Aberrant activation of neuronal cell cycle caused by dysregulation of ubiquitin ligase Itch results in neurodegeneration, Cell Death Dis., 11, 441, 10.1038/s41419-020-2647-1 · DOI · Paper page
  18. Hradek, 2015, Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer’s disease patients, J. Alzheimers Dis., 43, 57, 10.3233/JAD-141083 · DOI · Paper page
  19. Delobel, 2006, Cell-cycle markers in a transgenic mouse model of human tauopathy: Increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1, Am. J. Pathol., 168, 878, 10.2353/ajpath.2006.050540 · DOI
  20. Walton, 2018, Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons, Sci. Rep., 8, 14316, 10.1038/s41598-018-32708-4 · DOI · Paper page
  21. Marlier, 2020, Core cell cycle machinery is crucially involved in both life and death of post-mitotic neurons, Cell. Mol. Life Sci., 77, 4553, 10.1007/s00018-020-03548-1 · DOI
  22. Fujimaki, 2019, Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch, Proc. Natl. Acad. Sci. USA, 116, 22624, 10.1073/pnas.1915905116 · DOI · Paper page
  23. Quax, 2019, Regulation of Survival Networks in Senescent Cells: From Mechanisms to Interventions, J. Mol. Biol., 431, 2629, 10.1016/j.jmb.2019.05.036 · DOI · Paper page
  24. Kole, 2013, Mature neurons: Equipped for survival, Cell Death Dis., 4, e689, 10.1038/cddis.2013.220 · DOI · Paper page
  25. Oppenheim, 1991, Cell death during development of the nervous system, Annu. Rev. Neurosci., 14, 453, 10.1146/annurev.ne.14.030191.002321 · DOI · Paper page
  26. Wright, 2007, Chromatin modification of Apaf-1 restricts the apoptotic pathway in mature neurons, J. Cell Biol., 179, 825, 10.1083/jcb.200708086 · DOI · Paper page
  27. Donovan, 2002, Caspase-independent photoreceptor apoptosis in vivo and differential expression of apoptotic protease activating factor-1 and caspase-3 during retinal development, Cell Death Differ., 9, 1220, 10.1038/sj.cdd.4401105 · DOI
  28. Yakovlev, 2001, Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury, J. Neurosci., 21, 7439, 10.1523/JNEUROSCI.21-19-07439.2001 · DOI · Paper page
  29. Annis, 2016, Mature neurons dynamically restrict apoptosis via redundant premitochondrial brakes, FEBS J., 283, 4569, 10.1111/febs.13944 · DOI
  30. Xia, 2019, Cell Cycle Proteins as Key Regulators of Postmitotic Cell Death, Yale J. Biol. Med., 92, 641
  31. Ruben, 1986, Recombinant DNA produced human IL-2, injected in vivo, will substitute for carrier priming of helper function in the South African clawed toad, Xenopus laevis, Immunol. Lett., 13, 227, 10.1016/0165-2478(86)90106-9 · doi:10.1016/0165-2478(86)90106-9
  32. Walker, 2015, Neuropathologically mixed Alzheimer’s and Lewy body disease: Burden of pathological protein aggregates differs between clinical phenotypes, Acta Neuropathol., 129, 729, 10.1007/s00401-015-1406-3 · DOI · Paper page
  33. Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. USA, 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
  34. Piechota, 2016, Is senescence-associated beta-galactosidase a marker of neuronal senescence?, Oncotarget, 7, 81099, 10.18632/oncotarget.12752 · DOI · Paper page
  35. 2018, Myths and truths about the cellular composition of the human brain: A review of influential concepts, J. Chem. Neuroanat., 93, 2, 10.1016/j.jchemneu.2017.08.004 · DOI
  36. Garwood, 2020, Expression of p16 and p21 in the frontal association cortex of ALS/MND brains suggests neuronal cell cycle dysregulation and astrocyte senescence in early stages of the disease, Neuropathol. Appl. Neurobiol., 46, 171, 10.1111/nan.12559 · DOI · Paper page
  37. Trias, 2019, Emergence of Microglia Bearing Senescence Markers During Paralysis Progression in a Rat Model of Inherited ALS, Front. Aging Neurosci., 11, 42, 10.3389/fnagi.2019.00042 · DOI · Paper page
  38. Andreadis, 1992, Structure and novel exons of the human tau gene, Biochemistry, 31, 10626, 10.1021/bi00158a027 · DOI · Paper page
  39. Goedert, 1989, Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer’s disease, Neuron, 3, 519, 10.1016/0896-6273(89)90210-9 · DOI · Paper page
  40. Orr, 2017, A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies, Trends Pharmacol. Sci., 38, 637, 10.1016/j.tips.2017.03.011 · DOI · Paper page
  41. Marquez, 2021, Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy, Neurobiol. Dis., 151, 105273, 10.1016/j.nbd.2021.105273 · DOI
  42. Acklin, 2020, Depletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in mice, Sci. Rep., 10, 14170, 10.1038/s41598-020-71042-6 · DOI · Paper page
  43. Calls, 2021, Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response, Neuro Oncol., 23, 88, 10.1093/neuonc/noaa151 · DOI
  44. Ezquerra, M., Pastor, P., Gaig, C., Vidal-Taboada, J.M., Cruchaga, C., Munoz, E., Marti, M.J., Valldeoriola, F., Aguilar, M., and Calopa, M. (2011). Different MAPT haplotypes are associated with Parkinson’s disease and progressive supranuclear palsy. Neurobiol. Aging, 32. · DOI
  45. Davis, A.A., Andruska, K.M., Benitez, B.A., Racette, B.A., Perlmutter, J.S., and Cruchaga, C. (2016). Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiol. Aging, 37. · DOI
  46. Zhang, 2018, Tau Pathology in Parkinson’s Disease, Front. Neurol., 9, 809, 10.3389/fneur.2018.00809 · DOI · Paper page
  47. Lang, 1998, Parkinson’s disease. First of two parts, N. Engl. J. Med., 339, 1044, 10.1056/NEJM199810083391506 · DOI · Paper page
  48. Dauer, 2003, Parkinson’s disease: Mechanisms and models, Neuron, 39, 889, 10.1016/S0896-6273(03)00568-3 · DOI · Paper page
  49. Hernandez, 2005, Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers, Mol. Cell. Biochem., 278, 203, 10.1007/s11010-005-7499-6 · DOI
  50. Larriva, 2020, Overexpression of alpha-synuclein promotes both cell proliferation and cell toxicity in human SH-SY5Y neuroblastoma cells, J. Adv. Res., 23, 37, 10.1016/j.jare.2020.01.009 · DOI
  51. Yasui, 2002, SATB1 targets chromatin remodelling to regulate genes over long distances, Nature, 419, 641, 10.1038/nature01084 · DOI · Paper page
  52. Ho, 2019, Upregulation of the p53–p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of alpha-synuclein, Cell Cycle, 18, 467, 10.1080/15384101.2019.1577666 · DOI · Paper page
  53. Levy, 2009, Cell death pathways in Parkinson’s disease: Proximal triggers, distal effectors, and final steps, Apoptosis, 14, 478, 10.1007/s10495-008-0309-3 · DOI · Paper page
  54. Gralle, 2017, The neuronal insulin receptor in its environment, J. Neurochem., 140, 359, 10.1111/jnc.13909 · DOI · Paper page
  55. Liang, 2019, Mammalian Target of Rapamycin at the Crossroad Between Alzheimer’s Disease and Diabetes, Adv. Exp. Med. Biol., 1128, 185, 10.1007/978-981-13-3540-2_10 · DOI
  56. Kullmann, 2016, Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans, Physiol. Rev., 96, 1169, 10.1152/physrev.00032.2015 · DOI · Paper page
  57. Orr, 2014, Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer’s disease pathology, Neurobiol. Aging, 35, 1233, 10.1016/j.neurobiolaging.2013.12.006 · DOI · Paper page
  58. Yang, 2005, Loss of neuronal cell cycle control in ataxia-telangiectasia: A unified disease mechanism, J. Neurosci., 25, 2522, 10.1523/JNEUROSCI.4946-04.2005 · DOI · Paper page
  59. Arendt, 2010, Selective cell death of hyperploid neurons in Alzheimer’s disease, Am. J. Pathol., 177, 15, 10.2353/ajpath.2010.090955 · DOI · Paper page
  60. Toots, A., Rosendahl, E., Lundin-Olsson, L., Nordstrom, P., Gustafson, Y., and Littbrand, H. (2013). Usual gait speed independently predicts mortality in very old people: A population-based study. J. Am. Med. Dir. Assoc., 14. · DOI
  61. Blain, 2010, Balance and walking speed predict subsequent 8-year mortality independently of current and intermediate events in well-functioning women aged 75 years and older, J. Nutr. Health Aging, 14, 595, 10.1007/s12603-010-0111-0 · DOI · Paper page
  62. Goyal, 1982, Lipofuscin pigment accumulation in human brain during aging, Exp. Gerontol., 17, 481, 10.1016/S0531-5565(82)80010-7 · DOI
  63. Sitte, 2001, Lipofuscin accumulation in proliferating fibroblasts in vitro: An indicator of oxidative stress, Exp. Gerontol., 36, 475, 10.1016/S0531-5565(00)00253-9 · DOI
  64. Calvo, 2015, Susceptibility to excitotoxicity in aged hippocampal cultures and neuroprotection by non-steroidal anti-inflammatory drugs: Role of mitochondrial calcium, J. Neurochem., 132, 403, 10.1111/jnc.13004 · DOI
  65. Kim, Y., Park, J., and Choi, Y.K. (2019). The Role of Astrocytes in the Central Nervous System Focused on BK Channel and Heme Oxygenase Metabolites: A Review. Antioxidants, 8. · DOI · Paper page
  66. Cayre, 2009, Cell migration in the normal and pathological postnatal mammalian brain, Prog. Neurobiol., 88, 41, 10.1016/j.pneurobio.2009.02.001 · DOI · Paper page
  67. Sofroniew, 2010, Astrocytes: Biology and pathology, Acta Neuropathol., 119, 7, 10.1007/s00401-009-0619-8 · DOI · Paper page
  68. Contet, 2016, BK Channels in the Central Nervous System, Int. Rev. Neurobiol., 128, 281, 10.1016/bs.irn.2016.04.001 · DOI · Paper page
  69. Tabata, 2015, Diverse subtypes of astrocytes and their development during corticogenesis, Front. Neurosci., 9, 114, 10.3389/fnins.2015.00114 · DOI · Paper page
  70. Koontz, 2020, An update on human astrocytes and their role in development and disease, Glia, 68, 685, 10.1002/glia.23771 · DOI
  71. Jung, 2018, Phagocytic Roles of Glial Cells in Healthy and Diseased Brains, Biomol. Ther., 26, 350, 10.4062/biomolther.2017.133 · DOI · Paper page
  72. Munger, 2019, Astrocytic changes with aging and Alzheimer’s disease-type pathology in chimpanzees, J. Comp. Neurol., 527, 1179, 10.1002/cne.24610 · DOI · Paper page
  73. Boisvert, 2018, The Aging Astrocyte Transcriptome from Multiple Regions of the Mouse Brain, Cell Rep., 22, 269, 10.1016/j.celrep.2017.12.039 · DOI · Paper page
  74. Han, 2020, Astrocyte Senescence and Alzheimer’s Disease: A Review, Front. Aging Neurosci., 12, 148, 10.3389/fnagi.2020.00148 · DOI · Paper page
  75. Evans, 2003, A P53-dependent, telomere-independent proliferative life span barrier in human astrocytes consistent with the molecular genetics of glioma development, Cancer Res., 63, 4854
  76. Pertusa, 2007, Astrocytes aged in vitro show a decreased neuroprotective capacity, J. Neurochem., 101, 794, 10.1111/j.1471-4159.2006.04369.x · DOI · Paper page
  77. Karababa, 2015, Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy, Glia, 63, 37, 10.1002/glia.22731 · DOI · Paper page
  78. Eriksson, 2010, Radiation-induced cell death mechanisms, Tumour. Biol., 31, 363, 10.1007/s13277-010-0042-8 · DOI · Paper page
  79. Turnquist, 2016, p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration, Cell Death Differ., 23, 1515, 10.1038/cdd.2016.37 · DOI · Paper page
  80. Simmnacher, 2020, Unique signatures of stress-induced senescent human astrocytes, Exp. Neurol., 334, 113466, 10.1016/j.expneurol.2020.113466 · DOI
  81. Lye, 2019, Astrocyte senescence may drive alterations in GFAPα, CDKN2A p14(ARF), and TAU3 transcript expression and contribute to cognitive decline, Geroscience, 41, 561, 10.1007/s11357-019-00100-3 · DOI · Paper page
  82. Thal, 2019, Different aspects of Alzheimer’s disease-related amyloid beta-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia, Acta Neuropathol. Commun., 7, 178, 10.1186/s40478-019-0837-9 · DOI
  83. Fakhoury, 2018, Microglia and Astrocytes in Alzheimer’s Disease: Implications for Therapy, Curr. Neuropharmacol., 16, 508, 10.2174/1570159X15666170720095240 · DOI · Paper page
  84. Csipo, 2020, Astrocyte senescence contributes to cognitive decline, Geroscience, 42, 51, 10.1007/s11357-019-00140-9 · DOI
  85. Rajendran, 2013, The vascular endothelium and human diseases, Int. J. Biol. Sci., 9, 1057, 10.7150/ijbs.7502 · DOI · Paper page
  86. Greenwood, 2011, Review: Leucocyte-endothelial cell crosstalk at the blood-brain barrier: A prerequisite for successful immune cell entry to the brain, Neuropathol. Appl. Neurobiol., 37, 24, 10.1111/j.1365-2990.2010.01140.x · DOI · Paper page
  87. Barinda, 2020, Endothelial progeria induces adipose tissue senescence and impairs insulin sensitivity through senescence associated secretory phenotype, Nat. Commun., 11, 481, 10.1038/s41467-020-14387-w · DOI · Paper page
  88. Hayashi, 2006, Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes, Proc. Natl. Acad. Sci. USA, 103, 17018, 10.1073/pnas.0607873103 · DOI · Paper page
  89. Ekstrand, 2008, Environmental enrichment, exercise and corticosterone affect endothelial cell proliferation in adult rat hippocampus and prefrontal cortex, Neurosci. Lett., 442, 203, 10.1016/j.neulet.2008.06.085 · DOI
  90. Hobson, 1984, Endothelial proliferation in tumours and normal tissues: Continuous labelling studies, Br. J. Cancer, 49, 405, 10.1038/bjc.1984.66 · DOI · Paper page
  91. Stamatovic, 2008, Brain endothelial cell-cell junctions: How to “open” the blood brain barrier, Curr. Neuropharmacol., 6, 179, 10.2174/157015908785777210 · DOI · Paper page
  92. Cuevas, 2018, Isolation and Culture of Brain Microvascular Endothelial Cells for In Vitro Blood-Brain Barrier Studies, Methods Mol. Biol., 1727, 315, 10.1007/978-1-4939-7571-6_23 · DOI
  93. Song, 2020, Transcriptomic comparison of human and mouse brain microvessels, Sci. Rep., 10, 12358, 10.1038/s41598-020-69096-7 · DOI · Paper page
  94. Guerra, G., Lucariello, A., Perna, A., Botta, L., De Luca, A., and Moccia, F. (2018). The Role of Endothelial Ca(2+) Signaling in Neurovascular Coupling: A View from the Lumen. Int. J. Mol. Sci., 19. · DOI
  95. Pardridge, 2020, The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier, Front. Physiol., 11, 398, 10.3389/fphys.2020.00398 · DOI · Paper page
  96. Bauer, 2014, “You Shall Not Pass”—Tight junctions of the blood brain barrier, Front. Neurosci., 8, 392, 10.3389/fnins.2014.00392 · DOI · Paper page
  97. Soares, 2014, Aging and DNA damage in humans: A meta-analysis study, Aging, 6, 432, 10.18632/aging.100667 · DOI · Paper page
  98. Nation, 2019, Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction, Nat. Med., 25, 270, 10.1038/s41591-018-0297-y · DOI · Paper page
  99. Machida, 2017, Role of thrombin-PAR1-PKCtheta/delta axis in brain pericytes in thrombin-induced MMP-9 production and blood-brain barrier dysfunction in vitro, Neuroscience, 350, 146, 10.1016/j.neuroscience.2017.03.026 · DOI
  100. Brouns, 2011, Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome, Eur. Neurol., 65, 23, 10.1159/000321965 · DOI
  101. Zhang, 2018, Autophagy- and MMP-2/9-mediated Reduction and Redistribution of ZO-1 Contribute to Hyperglycemia-increased Blood-Brain Barrier Permeability During Early Reperfusion in Stroke, Neuroscience, 377, 126, 10.1016/j.neuroscience.2018.02.035 · DOI · Paper page
  102. Guilfoyle, 2015, Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study, J. Neurotrauma, 32, 1553, 10.1089/neu.2014.3764 · DOI
  103. Rao, 2007, MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway, Cancer Res., 67, 4956, 10.1158/0008-5472.CAN-07-0380 · DOI
  104. Bennett, 2018, Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease, Proc. Natl. Acad. Sci. USA, 115, E1289, 10.1073/pnas.1710329115 · DOI · Paper page
  105. Michalicova, 2020, Tau Protein and Its Role in Blood-Brain Barrier Dysfunction, Front. Mol. Neurosci., 13, 570045, 10.3389/fnmol.2020.570045 · DOI · Paper page
  106. Minamino, 2004, Vascular cell senescence and vascular aging, J. Mol. Cell. Cardiol., 36, 175, 10.1016/j.yjmcc.2003.11.010 · DOI
  107. Spazzafumo, 2017, Age-related modulation of plasmatic beta-Galactosidase activity in healthy subjects and in patients affected by T2DM, Oncotarget, 8, 93338, 10.18632/oncotarget.21848 · DOI
  108. Wagenaar, 2018, Origin and dynamics of oligodendrocytes in the developing brain: Implications for perinatal white matter injury, Glia, 66, 221, 10.1002/glia.23256 · DOI · Paper page
  109. Moore, 2020, A role of oligodendrocytes in information processing, Nat. Commun., 11, 5497, 10.1038/s41467-020-19152-7 · DOI · Paper page
  110. Giacci, 2018, Oligodendroglia Are Particularly Vulnerable to Oxidative Damage after Neurotrauma In Vivo, J. Neurosci., 38, 6491, 10.1523/JNEUROSCI.1898-17.2018 · DOI · Paper page
  111. Chen, 2007, DNA damage, cellular senescence and organismal ageing: Causal or correlative?, Nucleic Acids Res., 35, 7417, 10.1093/nar/gkm681 · DOI · Paper page
  112. Werkman, 2021, Macroglial diversity: White and grey areas and relevance to remyelination, Cell. Mol. Life Sci., 78, 143, 10.1007/s00018-020-03586-9 · DOI
  113. Simpson, 2015, Oxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain, Brain Pathol., 25, 565, 10.1111/bpa.12216 · DOI · Paper page
  114. Pruitt, 2013, Cdkn1b overexpression in adult mice alters the balance between genome and tissue ageing, Nat. Commun., 4, 2626, 10.1038/ncomms3626 · DOI
  115. Rueda, 2020, Cellular Senescence in Neurodegenerative Diseases, Front. Cell. Neurosci., 14, 16, 10.3389/fncel.2020.00016 · DOI · Paper page

Cited by

See all 55

Metadata

Authors
Sah, E., Krishnamurthy, S., Ahmidouch, M. Y., Gillispie, G. J., Milligan, C., & Orr, M. E.
Venue
Life
Publisher
MDPI AG
Published
2021-03-11
Volume
11
Issue
3
Pages
229
ISSN
2075-1729 (ISSN-L)
OpenAlex
W3135418239
Cited by
55
References
72
FWCI
4.83
Type
journal article
Language
en
Open access
gold
Funders
  • U.S. Department of Veterans Affairs (IK2BX003804)
  • National Institute on Aging (R01AG068293)
  • Cure Alzheimer's Fund (N/A)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Cellular Senescence Stress Response in Post-Mitotic Brain Cells: Cell Survival at the Expense of Tissue Degeneration. https://app.cochat.ai/papers/10.3390/life11030229
The paper
Sah, E., Krishnamurthy, S., Ahmidouch, M. Y., Gillispie, G. J., Milligan, C., & Orr, M. E. (2021). The Cellular Senescence Stress Response in Post-Mitotic Brain Cells: Cell Survival at the Expense of Tissue Degeneration. Life. https://doi.org/10.3390/life11030229

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.